Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

IGM Biosciences (IGMS)

  • Technical Exchange News
  • June 13, 2025, 18:47 UTC
  • 2

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

GT Biopharma Inc. (GTBP)

  • Technical Exchange News
  • June 13, 2025, 18:47 UTC
  • 2

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Ekso Bionics Holdings Inc (EKSO)

  • Technical Exchange News
  • June 13, 2025, 18:47 UTC
  • 2

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Spero Therapeutics Inc (SPRO)

  • Technical Exchange News
  • June 13, 2025, 01:37 UTC
  • 5

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Spero Therapeutics Inc (SPRO)

  • Technical Exchange News
  • June 12, 2025, 19:07 UTC
  • 2

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Mauna Kea Technologies (MKEAF)

  • Technical Exchange News
  • June 12, 2025, 09:50 UTC
  • 0

Grey symbol attribute type Security_Name was changed. Previous value: MASTERWORKS 020 LLC A. New value: MAUNA KEA TECHS NOM CATE.

Comment Full text

iSpecimen Inc (ISPC)

  • Technical Exchange News
  • June 12, 2025, 01:50 UTC
  • 2

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

I-Mab (IMAB)

  • Technical Exchange News
  • June 12, 2025, 01:50 UTC
  • 2

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

iSpecimen Inc (ISPC)

  • Technical Exchange News
  • June 11, 2025, 19:28 UTC
  • 2

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

I-Mab (IMAB)

  • Technical Exchange News
  • June 11, 2025, 19:28 UTC
  • 2

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next

Search

News categories

  • Technical Exchange News(9371)
  • Event(407)
  • SEC News(152917)
  • FDA Approval(8739)
  • Company Report(721)
  • Business News(104442)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin